Hubbry Logo
Third-degree atrioventricular blockThird-degree atrioventricular blockMain
Open search
Third-degree atrioventricular block
Community hub
Third-degree atrioventricular block
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Third-degree atrioventricular block
Third-degree atrioventricular block
Third-degree atrioventricular block
View on Wikipedia
from Wikipedia
Third-degree atrioventricular block
Other namesComplete heart block
12-lead ECG showing complete heart block
SpecialtyCardiology
SymptomsDizziness, Fainting, Shortness of breath, Sudden cardiac death
CausesFibrosis in cardiac conduction system, myocardial infarction, post-cardiac surgery, medication, vagal tone, electrolyte disturbances
Diagnostic methodElectrocardiogram
TreatmentPacemaker

Third-degree atrioventricular block (AV block) is a medical condition in which the electrical impulse generated in the sinoatrial node (SA node) in the atrium of the heart can not propagate to the ventricles.[1]

Because the impulse is blocked, an accessory pacemaker in the lower chambers will typically activate the ventricles. This is known as an escape rhythm. Since this accessory pacemaker also activates independently of the impulse generated at the SA node, two independent rhythms can be noted on the electrocardiogram (ECG).

  • The P waves with a regular P-to-P interval (in other words, a sinus rhythm) represent the first rhythm.
  • The QRS complexes with a regular R-to-R interval represent the second rhythm. The PR interval will be variable, as the hallmark of complete heart block is the lack of any apparent relationship between P waves and QRS complexes.

Presentation

[edit]

People with third-degree AV block typically experience severe bradycardia (an abnormally low measured heart rate), hypotension, and at times, hemodynamic instability.[2]

Cause

[edit]
Leads I and II demonstrating complete AV block. Note that the P waves are not related to the QRS complexes (PP interval and QRS interval both constant), demonstrating that the atria are electrically disconnected from the ventricles. The QRS complexes represent an escape rhythm arising from the ventricle.
Atrial tachycardia with complete A-V block and resulting junctional escape

Many conditions can cause third-degree heart block, but the most common cause is coronary ischemia. Progressive degeneration of the electrical conduction system of the heart can lead to third-degree heart block. This may be preceded by first-degree AV block, second-degree AV block, bundle branch block, or bifascicular block. In addition, acute myocardial infarction may present with third-degree AV block.[3]

An inferior wall myocardial infarction may cause damage to the AV node, causing third-degree heart block. In this case, the damage is usually transitory. Studies have shown that third-degree heart block in the setting of an inferior wall myocardial infarction typically resolves within 2 weeks.[4] The escape rhythm typically originates in the AV junction, producing a narrow complex escape rhythm.[citation needed]

An anterior wall myocardial infarction may damage the distal conduction system of the heart, causing third-degree heart block. Initially demonstrated by animal studies, this is due to a stark reduction in the Kv β-subunit of the voltage-gated K+ channels in the pacemaker cells of the atrioventricular junction, causing significantly decreased propagation of ions across gap junctions between cardiac cells and thus prolonging the PR interval.[5] This is typically extensive, permanent damage to the conduction system, eliciting a necessity for a permanent pacemaker to be placed.[6] The escape rhythm typically originates in the ventricles, producing a wide complex escape rhythm.

Third-degree heart block may also be congenital and has been linked to the presence of lupus in the mother.[7] It is thought that maternal antibodies may cross the placenta and attack the heart tissue during gestation. The cause of congenital third-degree heart block in many patients is unknown. Studies suggest that the prevalence of congenital third-degree heart block is between 1 in 15,000 and 1 in 22,000 live births.[citation needed]

Hyperkalemia in those with previous cardiac disease[8] and Lyme disease can also result in third-degree heart block.[9]

Hypermagnesemia

[edit]

AV block may be observed in patients with hypermagnesemia who are receiving excessive intravenous doses of magnesium sulfate.[10]: 281 

Diagnosis

[edit]

Diagnosis is largely focussed on analysis of the patients 12-lead ECG. A patient with a third-degree AV block will likely have p-waves not corresponding to QRS complexes along with bradycardia.

Treatment

[edit]

Atropine is often used as a first line treatment of a third-degree heart block in the presence of a narrow QRS which indicates a nodal block, but, may have little to no effect in an infra-nodal block.[11] Atropine works by reducing vagal stimulation through the AV node but will not be effective in those who have had a previous heart transplant.[12] Other drugs may be utilized such as epinephrine or dopamine which have positive chronotropic effects and may increase the heart rate.[13] Treatment in emergency situations can involve electrical transcutaneous pacing in those who are acutely hemodynamically unstable and can be used regardless of the persons level of consciousness.[14] Sedative agents such as a benzodiazepine or opiate may be used in conjunction with transcutaneous pacing to reduce the pain caused by the intervention.[13][14]

In cases of suspected beta-blocker overdose, the heart-block may be treated with pharmacological agents to reverse the underlying cause with the use of glucagon. In the case of a calcium channel blocker overdose treated with calcium chloride and digitalis toxicity may be treated with the digoxin immune Fab.[15]

Third-degree AV block can be treated more permanently with the use of a dual-chamber artificial pacemaker.[16] This type of device typically listens for a pulse from the SA node via lead in the right atrium and sends a pulse via a lead to the right ventricle at an appropriate delay, driving both the right and left ventricles. Pacemakers in this role are usually programmed to enforce a minimum heart rate and to record instances of atrial flutter and atrial fibrillation, two common secondary conditions that can accompany third-degree AV block. Since pacemaker correction of the third-degree block requires full-time pacing of the ventricles, a potential side effect is pacemaker syndrome, and may necessitate the use of a biventricular pacemaker, which has an additional 3rd lead placed in a vein in the left ventricle, providing more coordinated pacing of both ventricles.[citation needed]

The 2005 Joint European Resuscitation and Resuscitation Council (UK) guidelines[17] state that atropine is the first-line treatment especially if there were any adverse signs, namely: 1) heart rate < 40 bpm, 2) systolic blood pressure < 100 mm Hg, 3) signs of heart failure, and 4) ventricular arrhythmias requiring suppression. If these fail to respond to atropine or there is a potential risk of asystole, transvenous pacing is indicated. The risk factors for asystole include 1) previous asystole, 2) complete heart block with wide complexes, and 3) ventricular pause for > 3 seconds. Mobitz Type 2 AV block is another indication for pacing.

As with other forms of heart block, secondary prevention may also include medicines to control blood pressure and atrial fibrillation, as well as lifestyle and dietary changes to reduce risk factors associated with heart attack and stroke.

Early treatment of atrioventricular blockade is based on the presence and severity of symptoms and signs associated with ventricular escape rhythm. Hemodynamically unstable patients require immediate medication and in most cases temporary pacing to increase heart rate and cardiac output.

Once the patient is hemodynamically stable, a potentially reversible cause should be evaluated and treated. If no reversible cause is identified, a permanent pacemaker is inserted.[citation needed] Most stable patients have persistent bradycardia-related symptoms and require identification and treatment of any reversible cause or permanent implantable pacemaker.

Reversible causes of complete AV block should be ruled out before the insertion of a permanent pacemaker, such as drugs that slow heart rate and which induce hyperkalemia.

Complete atrioventricular block in acute myocardial infarction should be treated with temporary pacing and revascularization.[18][citation needed]

Complete atrioventricular block caused by hyperkalemia should be treated to lower serum potassium levels and patients with hypothyroidism should also receive thyroid hormone.[18]

If there is no reversible cause, the clear treatment of complete atrioventricular block is mostly permanent pacemaker placement.[citation needed]

Prognosis

[edit]

The prognosis of patients with complete heart block is generally poor without therapy. Patients with 1st and 2nd-degree heart block are usually asymptomatic.[19]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Third-degree atrioventricular block

View on Grokipedia
from Grokipedia
Third-degree atrioventricular block, also known as complete , is a severe cardiac conduction disorder characterized by the complete failure of electrical impulses to conduct from the atria to the ventricles, resulting in independent atrial and ventricular rhythms with no atrioventricular synchrony. This condition leads to a slowed ventricular rate, typically below 50 beats per minute, as the ventricles are driven by an escape rhythm originating from the AV junction or ventricles, often compromising and hemodynamic stability. It represents the most advanced form of and is considered a due to the risk of syncope, , or sudden if untreated. The etiology of third-degree AV block is diverse, encompassing degenerative processes such as idiopathic fibrosis of the conduction system, ischemic damage from (particularly inferior wall involvement in 5-10% of cases), medication toxicity (e.g., beta-blockers, , or ), infectious causes like , and iatrogenic factors including post-cardiac surgery complications. Epidemiologically, it has a low incidence in the general population of 0.02% to 0.04%, as low as approximately 0.001% in apparently healthy individuals but increasing significantly with comorbidities such as (up to 1.1%) or in the context of acute ST-elevation (around 2.2%). Pathophysiologically, the block can occur at the level of the AV node, His bundle, or distal , leading to atrioventricular dissociation where P waves march through independently of QRS complexes on . Clinically, patients may present asymptomatically if the escape rhythm is stable, but symptomatic cases often manifest with , , dyspnea, , or syncope due to and reduced ; physical examination may reveal , variable jugular venous pulsations from cannon A-waves, and signs of . Diagnosis is primarily confirmed via 12-lead electrocardiogram (ECG) demonstrating complete AV dissociation with atrial rates exceeding ventricular rates and no consistent relationship. Additional evaluation may include to assess structural heart disease, laboratory tests for reversible causes (e.g., electrolytes, Lyme ), and sometimes electrophysiological studies. Management prioritizes stabilization, with atropine as an initial pharmacologic intervention though often ineffective in infranodal blocks; transcutaneous or is urgently required for symptomatic , and permanent pacemaker implantation is indicated for persistent third-degree AV block to restore atrioventricular synchrony and prevent recurrence. Reversible causes, such as medication-induced block or acute ischemia, should be addressed promptly to potentially avoid long-term pacing. varies, with higher mortality in cases associated with anterior compared to inferior, underscoring the need for rapid intervention.

Background

Definition

Third-degree atrioventricular block, also known as complete or third-degree , is defined as the complete interruption of electrical impulses from the atria to the ventricles via the atrioventricular (AV) node, leading to atrioventricular dissociation where the atria and ventricles beat independently. Under normal conditions, electrical impulses originating from the pass through the AV node to the ventricles with a characteristic delay, corresponding to a of 0.12 to 0.20 seconds on , ensuring coordinated atrial and ventricular contraction. In third-degree AV block, this conduction pathway is entirely disrupted, preventing any atrial impulses from reaching the ventricles and requiring subsidiary pacemakers to generate ventricular beats. The atrial rhythm is typically driven by the at a rate of 60 to 100 beats per minute, while the ventricular rhythm arises from an escape focus, resulting in a slower rate of 40 to 60 beats per minute if the escape is junctional or 20 to 40 beats per minute if ventricular in origin. This condition represents the most severe form of AV block, in contrast to first- and second-degree blocks where partial conduction persists.

Classification

Atrioventricular (AV) blocks are classified into three degrees based on the extent of conduction delay or interruption between the atria and ventricles. First-degree AV block is characterized by a prolonged greater than 0.20 seconds on electrocardiogram (ECG), with consistent 1:1 conduction of P waves to QRS complexes. Second-degree AV block involves intermittent failure of conduction, subdivided into Mobitz type I (Wenckebach), where the PR interval progressively lengthens until a P wave is non-conducted, and Mobitz type II, featuring constant PR intervals with abrupt non-conduction of P waves. Third-degree AV block, also known as complete , represents total dissociation between atrial and ventricular activity, with no atrial impulses conducting to the ventricles; the atria are paced by the , while the ventricles rely on an independent escape rhythm. In third-degree AV block, the anatomical site of the block further refines classification and influences clinical implications. Blocks at the level of the AV node typically result in a junctional escape rhythm with narrow QRS complexes (duration <0.12 seconds) and a relatively stable rate of 40-60 beats per minute. In contrast, infranodal blocks, occurring below the AV node in the His-Purkinje system, produce a ventricular escape rhythm with wide QRS complexes (>0.12 seconds) and slower rates (20-40 beats per minute), carrying a worse due to the potential for hemodynamic instability and higher risk of progression or sudden events without intervention. Third-degree AV block is distinct from other conduction abnormalities, such as sinoatrial (SA) block, which affects impulse generation or exit from the SA node without impacting AV conduction directly, and bundle branch blocks, which involve delayed intraventricular conduction but preserve AV synchrony. These entities may coexist but do not equate to the complete AV dissociation defining third-degree block. Third-degree AV block can be broadly categorized as congenital or acquired, with the former typically identified , at birth, or within the first month of life, often associated with structural heart defects, while the latter develops later due to various insults. Lower-degree blocks, such as second-degree, may occasionally progress to third-degree, underscoring the importance of monitoring.

Pathophysiology

Conduction Disruption

In third-degree atrioventricular (AV) block, conduction disruption results in a complete failure of electrical impulses to propagate from the atria to the ventricles, despite normal atrial . Under normal conditions, the cardiac impulse originates in the sinoatrial (SA) node, spreads through the atria to the AV node, and then proceeds via the and to activate the ventricles. In this condition, however, the block interrupts this pathway at a specific site, leading to atrioventricular dissociation where atrial and ventricular activities occur independently. The site of the conduction block is most commonly the AV node (nodal block), occurring in the majority of cases and often reversible upon addressing the underlying cause, while infranodal blocks in the His-Purkinje system account for a substantial portion and are frequently irreversible due to extensive or ischemic damage. At the AV node, the block arises from progressive prolongation of the refractory period, extending beyond the atrial cycle length and preventing any supraventricular impulse from conducting to the ventricles, even as the atria continue to contract normally with regular P waves on . These P waves "march through" at their intrinsic rate, dissociated from the QRS complexes generated by a lower escape focus, reflecting total impulse failure at the block site. Contributing factors to this complete conduction halt include heightened , which predominantly affects the AV node by enhancing its refractory period; inflammatory processes that impair nodal or infranodal tissue integrity; ischemic that disrupts cellular excitability in the conduction pathway; and pharmacological agents that depress conduction to the point of zero propagation. In infranodal locations, structural degeneration from or sclerosis more commonly leads to abrupt and persistent block, as the His-Purkinje system's rapid conduction properties are particularly vulnerable to such insults. This electrophysiological interruption underscores the condition's reliance on subsidiary pacemakers below the block for ventricular activation.

Escape Rhythms and Hemodynamics

In third-degree atrioventricular block, the complete interruption of conduction between the atria and ventricles leads to the emergence of escape rhythms as a compensatory mechanism to maintain ventricular . The type and rate of the escape rhythm depend on the level of the block within the conduction system. If the block occurs at the level of the AV node, a junctional escape rhythm typically arises from the AV junction or His bundle, exhibiting a rate of 40 to 60 beats per minute and narrow QRS complexes (duration less than 120 ms) due to conduction through the normal His-Purkinje system. In contrast, an infranodal block below the AV node, involving the His-Purkinje system, results in a ventricular escape rhythm originating from the distal or ventricular myocardium, characterized by a slower rate of 20 to 40 beats per minute and wide QRS complexes (duration greater than 120 ms) owing to abnormal ventricular activation. This conduction failure manifests as atrioventricular dissociation, where atrial and ventricular activities proceed independently. The atria continue to be driven by the , producing P waves at their intrinsic rate (typically 60 to 100 beats per minute), while the ventricles rely on the slower escape rhythm, resulting in no fixed relationship between P waves and QRS complexes. The hemodynamic consequences of third-degree AV block stem primarily from the loss of atrioventricular synchrony and the bradycardic escape rates, profoundly impacting . is determined by the product of and (CO = HR × SV), and in this condition, the reduced —particularly when below 40 beats per minute—leads to a significant decline in CO, as the ventricles fail to receive the atrial "kick" that normally augments ventricular filling by 20-30%. This desynchronization also produces intermittent visible in the jugular venous pulse, arising from atrial contraction occurring against a closed when ventricular coincides with atrial . If the escape rhythm fails entirely, the condition can progress to , resulting in absent ventricular activity and immediate hemodynamic collapse.

Etiology

Acquired Causes

Acquired third-degree atrioventricular (AV) block refers to the complete interruption of electrical conduction between the atria and ventricles that develops during life, rather than from birth, and is most prevalent in adults over 60 years of age, with the incidence of third-degree AV block increasing with advancing age. These cases often stem from reversible factors such as metabolic derangements or iatrogenic influences, contrasted with irreversible structural changes from ischemia or degeneration, and account for the majority of third-degree AV blocks encountered in clinical practice. Ischemic heart disease, particularly acute (MI), is a leading acquired cause, occurring in up to 10% of inferior wall MIs due to transient ischemia of the AV node supplied by the , while anterior wall MIs more commonly involve infranodal structures via occlusion, leading to persistent block with poorer . Early has reduced the overall incidence of such blocks from historical rates of 5-7% to approximately 3.7%. Degenerative processes, such as Lenègre's disease—an idiopathic sclerodegenerative fibrosis primarily affecting the bundle branches—and Lev's disease—involving calcific infiltration of the conduction system—are common in elderly patients over 70 years and result in progressive loss of conduction tissue integrity without myocardial involvement. These fibrotic changes disrupt the His-Purkinje system, often leading to irreversible third-degree AV block requiring permanent pacing. Inflammatory and infectious etiologies include caused by , which infiltrates the AV node leading to reversible conduction block in up to 10% of untreated cases; viral or bacterial ; ; and , where immune-mediated damage scars the conduction pathways. Other examples encompass from and varicella-zoster virus infections, all of which can cause transient or permanent block through direct tissue inflammation or infiltration. Iatrogenic causes frequently arise from medications that depress AV nodal conduction, including beta-blockers, , , and antiarrhythmics like , particularly in overdose or with underlying conduction disease, often resolving upon discontinuation. Procedural interventions, such as (e.g., with 1-5.7% incidence of block) or catheter-based septal alcohol ablation and AV nodal ablation, can mechanically damage the conduction system, necessitating temporary pacing if the block persists beyond 4-5 days. Metabolic disturbances, such as , induce third-degree AV block by elevating extracellular potassium levels, which stabilize cardiac cell membranes, reduce phase 0 , and depress AV nodal excitability and conduction velocity, typically reversible with correction. similarly causes AV nodal depression through membrane stabilization and impaired excitability, often seen in renal failure or excessive magnesium administration. contributes via slowed metabolic and conduction rates in the AV node, with block improving after thyroid replacement.

Congenital Causes

Third-degree atrioventricular block can occur congenitally, either in isolation or in association with other cardiac anomalies, with an estimated incidence of 1 in 15,000 to 20,000 live births. Isolated congenital cases are particularly rare and often remain asymptomatic, potentially going undetected until adulthood when symptoms such as or syncope arise due to progressive conduction slowing. In contrast, when associated with structural heart disease, the block frequently presents earlier and is linked to defects such as (ASD), (VSD), or congenitally corrected transposition of the great arteries (ccTGA), where abnormal disrupts the atrioventricular conduction pathway during fetal development. A major etiology of congenital third-degree AV block is maternal autoimmune disease, especially systemic lupus erythematosus (SLE), mediated by transplacental passage of anti-Ro/SSA antibodies that trigger inflammation and fibrosis in the fetal conduction system. Offspring of mothers with these antibodies face approximately a 2% risk of developing the block, with cases often clustered in families due to recurrent antibody exposure in subsequent pregnancies. Genetic factors also contribute, notably mutations in the gene, which encodes the alpha subunit of the cardiac voltage-gated ; these loss-of-function variants impair impulse propagation and underlie progressive familial type IA, manifesting as early or progressive AV conduction defects from infancy. Clinically, congenital third-degree AV block is frequently identified in utero via fetal or in neonates who present with , sometimes accompanied by signs of low such as poor feeding or . The condition's course varies: some cases, particularly those tied to transient autoimmune , may partially resolve with recovery of conduction, while others progress inexorably, necessitating lifelong monitoring or intervention to prevent hemodynamic compromise. Overall, congenital forms are uncommon, comprising a small fraction of pediatric arrhythmias, with autoimmune-mediated instances showing a predisposition linked to maternal factors.

Clinical Presentation

Symptoms

Third-degree atrioventricular block often manifests with symptoms that depend on the ventricular escape rate and the duration of the block. Patients with an adequate escape rhythm exceeding 50 beats per minute are frequently at rest, as the heart maintains sufficient . However, when the escape rate falls below 40 beats per minute, individuals commonly report , , and dyspnea due to inadequate and reduced from and atrioventricular dissociation. In acute presentations, such as those associated with , symptoms can be more severe and include syncope, known as Stokes-Adams attacks, triggered by transient or profound leading to cerebral hypoperfusion. Additional acute symptoms may encompass and signs of , such as , reflecting ischemic or hemodynamic compromise. Chronic third-degree block typically presents with , as the fixed ventricular rate fails to increase appropriately with physical demand, limiting augmentation. may also occur due to atrioventricular dissociation, where atrial contractions against closed mitral and tricuspid valves create irregular sensations. In special populations, infants with congenital complete often exhibit poor feeding and secondary to fatigue during suckling and overall low . Among the elderly, can arise from cerebral hypoperfusion, particularly when escape rhythms are slow.

Physical Findings

Patients with third-degree atrioventricular block typically present with on assessment, with s often ranging from 30 to 50 beats per minute, reflecting the independent ventricular escape rhythm. may accompany this finding in symptomatic cases, particularly when the falls below 40 beats per minute, leading to reduced . Examination of the neck veins commonly reveals intermittent in the jugular venous pulse, resulting from atrial contraction against closed tricuspid and mitral valves due to atrioventricular dissociation. of the heart often discloses variable intensity of the first heart sound (S1), attributable to the inconsistent timing between atrial and ventricular contractions. An S3 gallop may be present if concomitant has developed, and murmurs related to bradycardia-induced hemodynamic changes or underlying structural issues can occasionally be heard. In acute presentations, general inspection may show , cool extremities, diaphoresis, and prolonged time, indicative of hypoperfusion from hemodynamic instability. In cases of congenital third-degree atrioventricular block, physical findings may include signs of associated congenital heart defects, such as from atrioventricular canal defects or other structural anomalies.

Diagnosis

Electrocardiographic Features

Third-degree atrioventricular (AV) block is diagnosed primarily through electrocardiographic (ECG) findings demonstrating complete AV dissociation, in which atrial and ventricular activities are entirely independent. This manifests as regular P waves occurring at the atrial rate, typically 60 to 100 beats per minute in , alongside regular QRS complexes at a slower ventricular escape rate, usually less than the atrial rate and often 20 to 50 beats per minute. There is no consistent relationship between P waves and QRS complexes, resulting in variable or absent PR intervals, as no atrial impulses conduct to the ventricles. The PP intervals remain constant, reflecting uninterrupted atrial depolarization, while the RR intervals are also constant, indicating a stable escape rhythm. The morphology of the QRS complexes further characterizes the level of conduction block. Narrow QRS complexes (duration <0.12 seconds) are observed in cases of AV nodal block, where the escape rhythm originates from the junctional tissue above the His bundle, producing a supraventricular-like waveform. In contrast, wide QRS complexes (>0.12 seconds) signify infranodal block, with the escape rhythm arising from the ventricles below the His-Purkinje system, often resulting in aberrant conduction and a slower rate (typically 20 to 40 beats per minute). This distinction is crucial for assessing hemodynamic stability, as junctional escapes are generally faster and narrower, while ventricular escapes are slower and wider. In rare instances, isoelectric AV dissociation may complicate ECG interpretation, where P waves are obscured or hidden within QRS complexes or T waves due to , potentially masking the full extent of dissociation. Careful measurement of PP and RR intervals, often using , is essential to identify the underlying independent rhythms in such cases. Additionally, a diagnostic hint distinguishing third-degree AV block from other forms of AV dissociation, such as those seen in , is the absence of ventricular capture during incremental atrial pacing; in complete block, increasing the atrial rate fails to conduct impulses to the ventricles, confirming the lack of AV nodal or infranodal conduction. This reflects the underlying pathophysiologic complete interruption of atrioventricular conduction.

Supporting Tests

Laboratory investigations are crucial for identifying reversible causes of third-degree atrioventricular block, such as disturbances or ischemia. Serum , particularly and magnesium, should be measured, as or hypomagnesemia can impair conduction and precipitate the block. levels are evaluated to detect myocardial ischemia or as an underlying . In patients with suspected autoimmune conditions, such as systemic lupus erythematosus or Sjögren's syndrome, (ANA) and anti-Ro/SSA antibody testing is recommended to identify immune-mediated contributions to the conduction abnormality. Imaging modalities provide insight into structural heart disease and ischemic causes. Transthoracic echocardiography is indicated to assess for , valvular abnormalities, or other structural issues that may contribute to the block, guiding further management decisions. Coronary angiography is performed in cases suggestive of to evaluate for obstructive lesions responsible for the conduction disturbance. Advanced electrophysiologic evaluation via an invasive electrophysiology study (EPS) helps localize the site of the block within the conduction system. During EPS, measurement of the HV interval (from His bundle deflection to ventricular activation) exceeding 70 ms signifies infranodal involvement, which carries a higher risk of progression and influences . monitoring, such as Holter , is useful for detecting intermittent or paroxysmal third-degree AV block and correlating episodes with symptoms in stable patients. Exercise testing can evaluate conduction behavior under physiologic stress but is contraindicated in symptomatic or hemodynamically unstable individuals due to the risk of worsening . Cardiac is not routinely employed but may be considered if or infiltrative myocardial disease is suspected based on clinical features.

Management

Acute Interventions

The initial management of third-degree atrioventricular (AV) block focuses on stabilizing the patient and addressing hemodynamic instability, following the advanced cardiovascular life support (ACLS) algorithm for unstable patients. This begins with ensuring airway, breathing, and circulation (ABCs), including maintenance of a patent airway, assisted ventilation if necessary, and supplemental oxygen for . Continuous cardiac monitoring, blood pressure assessment, , and establishment of intravenous (IV) access are essential, along with obtaining a 12-lead electrocardiogram (ECG) to confirm the without delaying . Identification of underlying causes, such as myocardial ischemia, drug toxicity, or electrolyte imbalances, should occur concurrently. Pharmacologic interventions serve as a bridge to pacing in symptomatic . Atropine, a first-line agent, is administered as 1 mg IV bolus, repeated every 3-5 minutes up to a maximum of 3 mg, to increase sinus node rate and potentially enhance AV nodal conduction; however, it is often ineffective in infranodal blocks due to its primary action at the AV node. If atropine fails, isoproterenol (1-20 mcg/min IV infusion) may be used as a to augment and AV conduction, particularly when pacing is unavailable. Alternative infusions include (5-20 mcg/kg/min IV) or epinephrine (2-10 mcg/min IV), titrated to response for temporary hemodynamic support in unstable cases. Reversible causes must be promptly identified and treated to potentially restore conduction and avoid unnecessary pacing. For hyperkalemia-induced block, IV calcium gluconate (10 mL of 10% solution over 2-5 minutes) is given to stabilize cardiac membranes and counteract arrhythmogenic effects, followed by measures like insulin-glucose infusion to shift potassium intracellularly. , often in renal failure, requires urgent dialysis if severe (>5 mEq/L) and symptomatic, as it prolongs AV conduction. , such as from beta-blockers, is managed with (3-10 mg IV bolus, followed by infusion if needed) to enhance myocardial contractility and rate via non-adrenergic pathways. Discontinuation of offending agents, like or , is critical, with specific antidotes (e.g., for ) used as indicated. For persistent symptomatic bradycardia (e.g., heart rate <40 bpm) or hemodynamic compromise unresponsive to pharmacology, temporary pacing is indicated per ACLS guidelines. Transcutaneous pacing provides immediate noninvasive support, with pads applied in anterior-posterior positions and energy titrated to achieve electrical and mechanical capture, often starting at 40-80 mA. If ineffective or intolerable, transvenous pacing is pursued within hours via femoral or internal jugular access for more reliable ventricular capture. These measures are prioritized in unstable patients with signs of shock, altered mental status, ischemia, or heart failure.

Definitive Therapy

The definitive therapy for third-degree atrioventricular (AV) block primarily involves permanent pacemaker implantation to restore effective cardiac rhythm and prevent life-threatening complications. According to the 2018 ACC/AHA/HRS guidelines, permanent pacing is indicated (Class I, Level of Evidence B-NR) for third-degree AV block not attributable to reversible or physiologic causes, regardless of symptoms, including asymptomatic cases with documented asystole greater than or equal to 3 seconds or an escape rate below 40 beats per minute. The 2021 ESC guidelines similarly recommend permanent pacing (Class I, Level C) for symptomatic third-degree AV block, such as syncope or heart failure, as well as asymptomatic cases with pauses exceeding 3 seconds or escape rates below 40 beats per minute, and for blocks persisting more than 5 days after myocardial infarction or cardiac surgery. In post-myocardial infarction settings, particularly infranodal blocks, pacing is essential due to the high risk of hemodynamic instability, while symptomatic blocks in any location warrant intervention to alleviate bradycardia-related symptoms. Permanent pacemakers are selected based on patient anatomy, sinus node function, and comorbidities, with dual-chamber (DDD) devices preferred to maintain atrioventricular synchrony and reduce risks like . The ACC/AHA guidelines endorse dual-chamber pacing over single-chamber ventricular pacing (VVI) (Class I, Level A) in patients with intact sinus node function, as it improves and hemodynamic performance by preserving atrial contribution to ventricular filling. VVI pacing is reserved for cases with chronic or limited life expectancy (Class IIa, Level B-R), providing reliable ventricular rate support without atrial leads. Emerging physiologic pacing options, such as conduction system pacing (CSP) including His-bundle pacing (HBP) and left bundle branch area pacing (LBBAP), are recommended by the 2025 ESC/EHRA consensus (Class I in select cases) for patients with AV block and reduced left ventricular (≤40%) to mimic natural conduction and prevent pacing-induced , showing comparable efficacy to biventricular pacing with lower thresholds and complication rates. Emerging leadless options, such as the Micra AV pacemaker, offer an alternative for select patients with high risk, venous access issues, or those requiring single-chamber pacing; the ESC guidelines support their use (Class IIa, Level B) in such scenarios, with real-world data showing high implantation success and low complication rates in AV block patients. In congenital third-degree AV block, surgical interventions are rare and typically limited to open-heart procedures addressing associated structural heart defects, with permanent pacing indicated if the block persists postoperatively or causes symptoms like bradycardia below 50 beats per minute or ventricular dysfunction. The ACC/AHA guidelines recommend pacing (Class I, Level C-LD) for congenital complete AV block with significant symptoms or dysfunction, often following initial surgical repair of anomalies such as ventricular septal defects. Permanent pacing is preferred over prolonged observation in high-risk congenital cases, though epicardial leads may be placed during concomitant cardiac surgery to avoid transvenous complications (ESC Class IIa, Level C). For reversible causes of third-degree AV block, such as or imbalances, definitive therapy shifts to monitoring after targeted treatment, with pacing deferred if conduction recovers. The ESC guidelines advise against permanent pacing (Class III, Level B) for blocks resolving after cause correction, exemplified by where antibiotics often restore AV conduction within weeks, allowing close observation rather than implantation. An observation period of 5-10 days post-myocardial infarction or 3-7 days post-surgery is recommended to assess reversibility before committing to permanent devices (Class I, Level C). Long-term follow-up after pacemaker implantation includes regular device to monitor lead function, battery life, and thresholds, typically every 6-12 months or via remote monitoring to enable early detection of issues. The ACC/AHA guidelines emphasize routine follow-up (Class I, Level B-NR) to ensure optimal device performance and . In patients with third-degree AV block and high risk for , such as those with or prior arrhythmias, an (ICD) may be combined with pacing (ESC Class IIa, Level C), particularly if left ventricular is below 50% or is evident on .

Prognosis

Outcomes

The prognosis for third-degree atrioventricular block varies significantly based on the underlying cause, the site of the block, patient age, and whether pacing therapy is implemented. With permanent pacemaker implantation, long-term is favorable, particularly in patients with isolated AV block, where observed 5-year survival rates have been reported as approximately 52% in older cohorts, though more recent data indicate improvements exceeding 80% at 3 years in patients with a mean age of 64 years. Untreated symptomatic cases carry a high risk of mortality, with 1-year rates as low as 68% and 5-year rates around 37% in historical untreated cohorts. Outcomes differ markedly by etiology. Reversible causes, such as drug-induced blocks (e.g., from beta-blockers or ), often lead to full recovery upon discontinuation of the offending agent, with AV conduction resolving in 41% of cases within 48 hours and spontaneous improvement in an additional 23%. In contrast, ischemic third-degree AV block associated with anterior portends a poor , with in-hospital mortality rates up to 20-33% even in the reperfusion era, reflecting extensive myocardial damage; blocks associated with inferior generally have better outcomes as they are often transient and nodal in location. For congenital third-degree AV block, pacemaker therapy yields highly favorable long-term outcomes, with very low overall mortality in paced children and adults despite a risk of disease progression requiring pacing upgrades. Prognostic factors include age and the type of escape rhythm. Patients over 70 years often experience worse outcomes due to comorbidities, with higher mortality risks compared to younger individuals. A junctional escape rhythm confers a better than a ventricular escape rhythm, as the former typically provides a more reliable and faster rate (40-60 bpm), reducing the likelihood of hemodynamic instability. Recent advancements up to 2025 have further improved outcomes through leadless pacemakers, which reduce infection risks compared to traditional transvenous devices; studies report 90% freedom from major complications at 90 days and lower revision rates (3.2% at 5 years), enhancing in AV block patients.

Complications

If left untreated, third-degree atrioventricular block can lead to sudden cardiac death due to or ventricular tachyarrhythmias triggered by -induced QT prolongation. Chronic and reduced cardiac output may precipitate through sustained low and neuroendocrine activation. Blood stasis from diminished ventricular filling increases the risk of . Syncope from hemodynamic instability often results in falls, causing musculoskeletal injuries or head trauma. Pacemaker implantation, the primary management strategy, carries procedural and long-term risks. Lead occurs in 1-2% of cases, with higher rates (up to 7%) in patients with prior temporary pacing. Cardiac affects 0.1-0.8% of implantations, potentially leading to or . Single-chamber ventricular pacing can cause in over 18-20% of patients, manifesting as , dyspnea, and from atrioventricular dyssynchrony. Battery depletion requires periodic device replacement, with failure risks escalating after 5-10 years depending on usage. The underlying etiology may contribute additional sequelae. In congenital cases, particularly autoimmune-mediated, progression to develops in 5-30% of patients. Post-myocardial infarction, the block heightens vulnerability to further ventricular arrhythmias. Rarely, association with sick sinus syndrome can result in tachy-brady syndrome, featuring paroxysmal alternating with profound . Early pacemaker implantation mitigates these risks, improving survival and reducing heart failure incidence compared to conservative management.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK545199/
  2. https://www.heart.org/en/health-topics/arrhythmia/about-arrhythmia/conduction-disorders
  3. https://emedicine.medscape.com/article/162007-overview
  4. https://www.merckmanuals.com/professional/cardiovascular-disorders/specific-cardiac-arrhythmias/atrioventricular-block
  5. https://www.ncbi.nlm.nih.gov/books/NBK459147/
  6. https://litfl.com/av-block-3rd-degree-complete-heart-block/
  7. https://emedicine.medscape.com/article/151597-overview
  8. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000628
  9. https://www.ncbi.nlm.nih.gov/books/NBK563205/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC10334430/
  11. https://pubmed.ncbi.nlm.nih.gov/37465444/
  12. https://www.jacc.org/doi/10.1016/j.jacep.2015.09.005
  13. https://litfl.com/lenegre-lev-disease/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC1768656/
  15. https://journals.lww.com/htin/fulltext/2017/05020/a_case_report_of_complete_atrioventricular_heart.14.aspx
  16. https://emedicine.medscape.com/article/894703-overview
  17. https://rarediseases.org/rare-diseases/heart-block-congenital/
  18. https://www.ahajournals.org/doi/10.1161/circulationaha.108.773143
  19. https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-023-03246-w
  20. https://www.ahajournals.org/doi/10.1161/hc0302.102592
  21. https://emedicine.medscape.com/article/894703-clinical
  22. https://www.ahajournals.org/doi/10.1161/circulationaha.107.735118
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC5005411/
  24. https://my.clevelandclinic.org/health/diseases/24644-stokes-adams-syndrome
  25. https://www.luriechildrens.org/en/specialties-conditions/heart-block/
  26. https://emedicine.medscape.com/article/162007-clinical
  27. https://www.ahajournals.org/doi/10.1161/01.cir.0000091380.04100.84
  28. https://teachim.org/teaching_material/3rd-degree-complete-heart-block/
  29. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430927/
  30. https://www.jacc.org/doi/10.1016/j.jacc.2013.10.086
  31. https://emedicine.medscape.com/article/162007-workup
  32. https://cpr.heart.org/-/media/CPR-Files/CPR-Guidelines-Files/2025-Algorithms/Algorithm-ACLS-Bradycardia-250514.pdf?sc_lang=en
  33. https://emedicine.medscape.com/article/162007-treatment
  34. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000627
  35. https://www.escardio.org/The-ESC/Press-Office/Press-releases/Groundbreaking-consensus-statement-on-conduction-system-pacing-released-a-major-milestone-in-the-evolution-of-pacing-therapy
  36. https://www.heartrhythmjournal.com/article/S1547-5271%2824%2902684-5/fulltext
  37. https://pubmed.ncbi.nlm.nih.gov/8074038/
  38. https://journals.sagepub.com/doi/10.1177/26324636251348302
  39. https://pubmed.ncbi.nlm.nih.gov/1015354/
  40. https://pubmed.ncbi.nlm.nih.gov/15234417/
  41. https://www.sciencedirect.com/science/article/pii/S2666668522000209
  42. https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2796.1999.00521.x
  43. https://ecgwaves.com/topic/ecg-third-degree-av-block-iii-3-criteria-management/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC11958420/
  45. https://www.sciencedirect.com/science/article/pii/S1547527124026845
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC3309429/
Add your contribution
Related Hubs
User Avatar
No comments yet.